BLRX - BioLineRx Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts2232
Avg. Estimate-0.15-0.16-0.43-0.28
Low Estimate-0.15-0.17-0.68-0.55
High Estimate-0.15-0.16-0.02-0.01
Year Ago EPS-0.15-0.15-0.45-0.43
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts2232
Avg. EstimateN/AN/A3.05M16.55M
Low EstimateN/AN/A1.46M10.53M
High EstimateN/AN/A5.89M22.57M
Year Ago SalesN/AN/AN/A3.05M
Sales Growth (year/est)N/AN/AN/A442.60%
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-0.11-0.15-0.12-0.17
EPS Actual-0.15-0.15-0.15-0.15
Difference-0.040-0.030.02
Surprise %-36.40%0.00%-25.00%11.80%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.15-0.16-0.43-0.28
7 Days Ago-0.15-0.16-0.63-0.55
30 Days Ago-0.15-0.16-0.59-0.53
60 Days Ago-0.15-0.16-0.59-0.53
90 Days Ago-0.12-0.14-0.38-0.22
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBLRXIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.-6.70%N/AN/AN/A
Current Year4.40%N/AN/AN/A
Next Year34.90%N/AN/AN/A
Next 5 Years (per annum)-25.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A